Showing results (161-170 of 381) with videos related to

Sort By:
Pageof 39
Academic Radiology|March 11, 2015
Liver enzyme levels and hepatic iron content in Fatty liver: a noninvasive assessment in general population by T2* mappingAmir Reza Radmard, Hossein Poustchi, Mehrdad Dadgostar, et al.
Archives of Iranian Medicine|March 2, 2019
The PERSIAN Guilan Cohort Study (PGCS)Fariborz Mansour-Ghanaei, Farahnaz Joukar, Mohammad Reza Naghipour, et al.
BMC Microbiology|June 30, 2019
Assessment of the impact of different fecal storage protocols on the microbiota diversity and composition: a pilot studyShirin Moossavi, Phillip A Engen, Reza Ghanbari, et al.
Archives of Iranian Medicine|August 13, 2015
PolyPill for Prevention of Cardiovascular Disease in an Urban Iranian Population with Special Focus on Nonalcoholic Steatohepatitis: A Pragmatic Randomized Controlled Trial within a Cohort (PolyIran - Liver) - Study ProtocolShahin Merat, Hossein Poustchi, Karla Hemming, et al.
Hepatitis Monthly|December 21, 2013
Prevalence and risk factors of hepatitis C virus infection in amol city, north of iran: a population-based study (2008-2011)Farhad Zamani, Masoudreza Sohrabi, Hossein Poustchi, et al.
Middle East Journal of Digestive Diseases|October 29, 2021
Prevalence of Hepatitis B and C Infections and Associated Risk Factors in Pars Cohort Study, Southern IranSanam Hariri, Sabereh Davari, Zeinab Malekzadeh, et al.
International Journal of Cardiology. Cardiovascular Risk and Prevention|May 23, 2024
The contribution of metabolic risk factors to cardiovascular mortality in Golestan cohort study: Population attributable fraction estimationFateme Gorgani, Maryam Sharafkhah, Sahar Masoudi, et al.
BMC Public Health|June 16, 2026
The association between dietary total, animal and plant protein and macronutrient substitution; and the risk of all-cause, cardiovascular or cancer mortality in the Golestan cohort studyFatemeh Toorang, Bahareh Sasanfar, Maryam Sharafkhah, et al.
The International Journal on Drug Policy|July 16, 2019
An intervention to improve HCV testing, linkage to care, and treatment among people who use drugs in Tehran, Iran: The ENHANCE studyMaryam Alavi, Hossein Poustchi, Shahin Merat, et al.
Middle East Journal of Digestive Diseases|March 3, 2016
Epidemiological Profile of Hepatitis B Virus Infection in Iran in the Past 25 years; A Systematic Review and Meta-analysis of General Population StudiesZahra Mohammadi, Abbasali Keshtkar, Sareh Eghtesad, et al.
Pageof 39